SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-16-000772
Filing Date
2016-05-13
Accepted
2016-05-13 13:03:00
Documents
49
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 g8224.htm 10-Q 580431
2 ex10-1.htm EX-10.1 73043
3 ex31-1.htm EX-31.1 15439
4 ex31-2.htm EX-31.2 15451
5 ex32.htm EX-32 6927
  Complete submission text file 0001165527-16-000772.txt   2715710

Data Files

Seq Description Document Type Size
6 clcs-20160331.xml EX-101.INS 472434
7 clcs-20160331.xsd EX-101.SCH 24808
8 clcs-20160331_cal.xml EX-101.CAL 27744
9 clcs-20160331_def.xml EX-101.DEF 76124
10 clcs-20160331_lab.xml EX-101.LAB 228639
11 clcs-20160331_pre.xml EX-101.PRE 158827
Mailing Address 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address 65 YIGAL ALON STREET TEL AVIV L3 67433 011 972 3 562-1755
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 161647220
SIC: 2834 Pharmaceutical Preparations